Last update 20 Mar 2025

YDE-011

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
synthetic peptides(Yuyu Pharma/Iris Pharma)
Target-
Action-
Mechanism-
Therapeutic Areas
Eye Diseases
Active Indication
Xerophthalmia
Inactive Indication-
Originator Organization
Yuyu Pharma, Inc.Yuyu Pharma, Inc.
Active Organization
Yuyu Pharma, Inc.Yuyu Pharma, Inc.
Inactive Organization
ABIONYX Pharma SAABIONYX Pharma SA
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with YDE-011
Login to view more data
100 Translational Medicine associated with YDE-011
Login to view more data
100 Patents (Medical) associated with YDE-011
Login to view more data
1
Literatures (Medical) associated with YDE-011
Investigative Ophthalmology & Visual Science
Dry Eye: Efficacy evaluation of three synthetic peptides from Chondrocyte-Derived ExtraCellular Matrix (CDEM) in comparison to lifitegrast, cyclosporine A, diquafosol sodium and sodium hyaluronate in a mouse model
100 Deals associated with YDE-011
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
XerophthalmiaPhase 1
South Korea
ABIONYX Pharma SAABIONYX Pharma SA
-
XerophthalmiaPreclinical
South Korea
Yuyu Pharma, Inc.Yuyu Pharma, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free